Dollard des Ormeaux, Canada

Mark Abramovitz


Average Co-Inventor Count = 5.8

ph-index = 8

Forward Citations = 151(Granted Patents)


Location History:

  • Quebec, CA (1998)
  • Dollard de Ormeaux, CA (1998)
  • Dollard des Ormeaux, CA (1996 - 2002)
  • Dollar des Ormeaux, CA (1999 - 2002)

Company Filing History:


Years Active: 1996-2002

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Innovator Mark Abramovitz: Pioneering Research in Prostaglandin Receptors

Introduction

Mark Abramovitz, a distinguished inventor based in Dollard des Ormeaux, CA, has made significant contributions in the field of biochemistry, holding 11 patents to his name. His innovative work primarily focuses on the identification of modulators related to prostaglandin receptors, which play crucial roles in various physiological processes.

Latest Patents

Among his latest patents, Abramovitz has developed methods for identifying modulators of two specific prostaglandin receptors. The first patent involves the identification of a human prostaglandin receptor. This innovation includes isolating, purifying, sequencing, and expressing the DNA that encodes the receptor in host cells. This advancement allows for effectively identifying modulators that can interact with the prostaglandin receptor.

His second recent patent focuses on a novel prostaglandin receptor, similarly highlighting the processes of isolating and expressing DNA encoding the receptor in host cells. Through this work, Abramovitz continues to advance the understanding of how these receptors can be modulated, potentially leading to new therapeutic approaches.

Career Highlights

Throughout his career, Mark Abramovitz has worked with leading pharmaceutical companies, notably Merck Frosst Canada, Inc. and Merck Frosst Canada & Co. His tenure at these organizations not only honed his expertise but also facilitated significant research and development in the field of drug discovery.

Collaborations

Abramovitz has collaborated with notable professionals in the industry, including Kathleen M Metters and Deborah M Slipetz. These partnerships have enabled him to integrate diverse perspectives and expertise into his work, contributing to his success as an inventor.

Conclusion

Mark Abramovitz's contributions in the realm of prostaglandin receptor research exemplify the impact that dedicated inventors can have in advancing science and medicine. With a remarkable patent portfolio and a career marked by innovative collaborations, Abramovitz continues to pave the way for future discoveries in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…